Proteomics International is proud to announce it has secured CE Mark registration for PromarkerD...
CE Mark for PromarkerD Hub predictive software for DKD
CE Mark registration received for the PromarkerD Hub – a software tool used to calculate the risk of kidney disease in patients with type 2 diabetes. Registration complements the recent CE Mark for PromarkerD (MS) giving a complete package of approvals for PromarkerD in the EU and a significant foundation for future regulatory approvals in other jurisdictions, specifically US FDA registration.